« Back to Record
Llombart-Cussac, A., Prat, A., Pérez-García, J. M., Mateos, J., Pascual, T., Escrivá-de-Romani, S., Stradella, A., Ruiz Borrego, M., de las Heras, B., Keyaerts, M., Galvan, P., Brasó-Maristany, F., García-Mosquera, J. J., Guiot, T., Gion, M., Sampayo-Cordero, M., Di Cosimo, S., Pérez-Escuredo, J., de Frutos, M. A., Cortes, J., & Gebhart, G. (2024). Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial. European journal of nuclear medicine and molecular imaging. doi:10.1007/s00259-024-06683-0
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/373778



